Brief: Chordate Medical Begins Market Introduction Of Migraine Treatment In Israel

Chordate Medical Holding AB (publ)

22/08/2022 08:09

Aug 22 (Reuters) - Chordate Medical Holding publ AB
 CMHM.ST :
    * BEGINS MARKET INTRODUCTION OF MIGRAINE TREATMENT IN ISRAEL
    * ENTERED INTO AN AGREEMENT WITH MARKET RELATIONS COMPANY
PHARMORE
PSR LTD, ISRAEL, TO INTRODUCE COMPANYS PRODUCT FOR PREVENTIVE
MIGRAINE TREATMENT ON ISRAELI MARKET
    * AGREEMENT WITH CHORDATES FORMER DISTRIBUTOR HAS BEEN
TERMINATED

Source text for Eikon:  ID:nBQNc7W3gR 
Further company coverage:  CMHM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))